Rocket Lab stock climbed 4.71% on Monday as investors reversed last week’s losses following Congress’ decision to reject funding for a 2031 Mars sample-return mission. The funding setback had weighed on sentiment, prompting the rebound as market participants recalibrated the company’s near-term launch and research prospects.

Renewed speculation of a future SpaceX IPO with potential valuations above $1.5 trillion prompted investors to lock in gains from public space-related stocks. This rotation away from existing launch and satellite names contributed to recent volatility in Rocket Lab shares as traders positioned capital for a possible SpaceX listing.

Rocket Lab is trading 9.9% below its 20-day simple moving average while remaining 20.5% above its 100-day average, reflecting mixed short-term momentum but sustained longer-term strength. With a 12-month gain of 147.27%, a neutral RSI reading of 45.23 and a MACD below its signal line, the stock faces key support at $67.00 and resistance at $80.00.